New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
16:25 EDTNSTGNanoString reports Q2 EPS (78c), consensus (65c)
Reports Q2 revenue $10.9M, consensus $10.15M. Reports cumulative installed base of approximately 220 nCounter Analysis Systems and 500 publications.
News For NSTG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 8, 2014
16:07 EDTNSTGNanoString updates Prosigna FDA labeling
NanoString Technologies announced that the FDA has cleared a labeling update for the Prosigna Breast Cancer Gene Signature Assay. The labeling update is derived from the analysis of data by researchers from the Austrian Breast and Colorectal Cancer Study Group Trial 8, or ABCSG-8, who previously reported that the Prosigna Assay accurately assessed the probability of distant recurrence in postmenopausal women with Estrogen Receptor-Positive, or ER+, early-stage breast cancer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use